Within the beneficial effects of omega-3 supplementation in NAFLD subjects, improvements in visceral adiposity index, HDL, and decreases in LDL, TG, GGT, and ALT can be detailed [185,189,190,191]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.